WHO approves use of experimental drug ZMapp against Ebola Virus
The World Health Organisation (WHO) has approved the use of drug ZMapp to combat Ebola spread as the death count surged.
The WHO decision comes after a US firm Mapp Biopharmaceutical supplied ZMapp to treat two US health workers who contracted the Ebola virus while treating Ebola affected patients in Liberia. The drug has shown some positive effects in saving the lives of Ebola-infected people.
The WHO has decided that the experimental drugs should be used with all transparency including aspects of care, freedom of choice, confidentiality, respect for the person and preservation of dignity. Doctors would not administer ZMapp without consent of the patients.
The current outbreak of Ebola is seen as the most terrible since the discovery of Ebola Virus. At present, there is no cure for Ebola. Recently, Mapp Biopharmaceutical offered the drug ZMapp to two US doctors who got affected with the Ebola disease.
The drug uses a novel method of passive immunization to treat Ebola disease by inserting genetically altered Ebola protein into tobacco leaves. However, it has been tested only on monkeys so far and it was to be tested on human volunteers in 2015. The abrupt outbreak of Ebola hastened the development.
US Gas Shortage 2021
The gasoline shortages in the US East Coast recently began to ease since the Colonial Pipeline Cyber...
What are Notified Diseases?
The Black Fungus disease has been declared as notified disease in Haryana. This means that the Gover...
What is the Heartbeat Bill?
Texas recently passed the Heartbeat Bill. It is a controversial bill in the United States. The bill ...
What is Nok Culture?
The scientists from the University of Bristol and Goethe University have found traces of bee wax in ...
Vineyard Wind Project
Vineyard Wind Project is the first major Offshore wind farm that is to power 400,000 homes. The proj...
|View All E-Books: Recent Release|